StockNews.com Initiates Coverage on Brooklyn ImmunoTherapeutics (NYSE:BTX)

Stock analysts at StockNews.com initiated coverage on shares of Brooklyn ImmunoTherapeutics (NYSE:BTX – Get Free Report) in a note issued to investors on Monday. The firm set a “hold” rating on the stock. Brooklyn ImmunoTherapeutics Stock Performance NYSE BTX opened at $0.34 on Monday. The business’s fifty day moving average is $0.35 and its 200 […]

Feb 12, 2025 - 07:27
 0
StockNews.com Initiates Coverage on Brooklyn ImmunoTherapeutics (NYSE:BTX)
Stock analysts at StockNews.com initiated coverage on shares of Brooklyn ImmunoTherapeutics (NYSE:BTX – Get Free Report) in a note issued to investors on Monday. The firm set a “hold” rating on the stock. Brooklyn ImmunoTherapeutics Stock Performance NYSE BTX opened at $0.34 on Monday. The business’s fifty day moving average is $0.35 and its 200 […]